Update: influenza activity--United States, 2004-05 season

    Insights

    This report details US influenza activity from October 2004 to March 2005, noting moderate national levels peaking in February. It also outlines the 2005-06 influenza vaccine composition.

    Area of Science:

    • Epidemiology
    • Public Health
    • Virology

    Background:

    • Influenza surveillance is crucial for monitoring disease activity and informing public health interventions.
    • Understanding regional variations in influenza activity helps tailor prevention strategies.

    Purpose of the Study:

    • To summarize influenza activity in the United States for the 2004-2005 season.
    • To update previous surveillance reports.
    • To describe the composition of the 2005-2006 influenza vaccine.

    Main Methods:

    • Utilized data from the seven components of the Centers for Disease Control and Prevention (CDC) Influenza Surveillance system.
    • Collected and analyzed influenza activity data from October 3, 2004, to March 26, 2005.

    Main Results:

    • Overall influenza activity in the United States was moderate during the study period.
    • Influenza activity demonstrated regional variations across the country.
    • National influenza activity reached its peak in early February, based on preliminary data.

    Conclusions:

    • The 2004-2005 influenza season was characterized by moderate, regionally variable activity peaking in early February.
    • The findings underscore the importance of ongoing influenza surveillance.
    • Information on vaccine composition is vital for future preparedness.

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Vaccinations01:51

    Vaccinations

    Overview
    Inhibitors Of Virion Release01:25

    Inhibitors Of Virion Release

    Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
    Infectious Diseases and Their Occurrence01:28

    Infectious Diseases and Their Occurrence

    Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.